Bush II: FDA’s Crawford Expected To Stay Awhile
This article was originally published in The Tan Sheet
The Bush Administration does not appear to have any imminent plans to replace FDA Acting Commissioner Lester Crawford, PhD, during the President's second term
You may also be interested in...
FDA will employ a "signal detection" process for evaluating and monitoring safety issues related to supplements on the market
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Combe sells most of its OTC brands